Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Oxycodone and fentanyl are both potent opioid analgesics used for pain management. When combined, they represent a powerful pain management approach, though this specific combination is not typically prescribed as a single formulation. **Oxycodone** is a semi-synthetic opioid analgesic that acts on mu-, kappa-, and delta-type opioid receptors. It is approximately 1.5 times more potent than oral morphine and is used for moderate to severe pain. It is available in immediate-release and extended-release formulations. **Fentanyl** is a synthetic opioid that is approximately 100 times more potent than morphine and 50 times more potent than heroin. It is FDA-approved for use as an analgesic and anesthetic, primarily used for severe pain management, including cancer pain and post-surgical pain. Both medications can cause respiratory depression, sedation, euphoria, and have high potential for dependence and abuse.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on oxycodone + fentanyl.